(92), 91 (100) (Found MHϩ: 500.1911. Calc. for C27H34NO4S2:
500.1929).
(3H, s, CH3), 2.13–1.51 (8H, m, CH2); E-isomer δ 7.99 (2H, d,
J 7.5, Ar-H), 7.78–7.76 (2H, m, Ar-H), 7.69 (1H, t, J 7.5, Ar-
H), 7.59 (2H, t, J 7.5, Ar-H), 7.22 (2H, d, J 8.1, Ar-H), 5.88–
5.86 (1H, m, 11-H), 5.82–5.74 (1H, m, 6-H or 7-H), 5.34–5.30
(1H, m, 6-H or 7-H), 4.91–4.89 (1H, m, 2-H), 4.03–4.01 (1H, m,
9-H), 2.40 (3H, s, CH3), 2.41–2.33, 2.24–2.17, 2.04–1.99, 1.92–
1.87, 1.79–1.73 (10H, 5 × m, CH2); 13C NMR (100 MHz, C6D6)
both isomers δ 143.6, 138.5, 135.5, 134.8, 133.6, 129.5, 129.1,
128.7, 128.1 (Ar-C, 1), 137.5 (6 or 7), 123.0, 120.3 (6 or 7, 11),
64.1, 61.6 (2, 9), 35.6, 32.1, 31.3, 26.9, 25.8 (CH2), 21.5 (CH3);
m/z 457 (Mϩ, 20%), 316 (90), 149 (75), 91 (100) (Found Mϩ:
457.1390. Calc. for C24H27NO4S2 457.1382).
2-Allyl-5-(1-phenylsulfonyloct-7-enyl)-1-(4-tolylsulfonyl)-2,3-
dihydro-1H-pyrrole (11d). According to general procedure A,
the alkylation of sulfone 10 (120 mg, 288 µmol) with 7-
iodohept-1-ene (0.13 ml, >570 µmol, >2.0 equiv.) afforded 11d
(121 mg, 82%) as a colourless oil and as a 79:21 mixture of
diastereomers: νmax/cmϪ1 3071, 2926, 1641, 1598, 1350, 1308,
1
1168, 1152; H NMR (400 MHz, C6D6) major diastereomer
(2S*, 1ЈS*) δ 8.02 (2H, d, J 7.4, Ar-H), 7.76 (2H, d, J 8.2,
Ar-H), 7.70 (1H, t, J 7.4, Ar-H), 7.61 (2H, t, J 7.4, Ar-H), 7.30
(2H, d, J 8.2, Ar-H), 5.89 (1H, m, 4-H), 5.81–5.70 (2H, m, 7Ј-H,
CH CH᎐CH ), 5.10–5.07 (2H, m, 8Ј-H or CH CH᎐CH ), 5.06–
(2S*,10S*,E)-
and
(2S*,10S*,Z)-2-Phenylsulfonyl-13-
᎐
᎐
2
2
2
2
5.03 (1H, m, 1Ј-H), 4.98–4.90 (2H, m, 8Ј-H or CH CH᎐CH ),
(toluene-4-sulfonyl)-13-azabicyclo[8.2.1]trideca-1(12),7-diene
(12c). According to general procedure B, a metathesis reaction
on triene 11c (9.5 mg, 19 µmol) afforded bicycle 12c (7.5 mg,
84%) as a colourless oil and as a 31:69 mixture of E/Z-isomers
[the Z-isomer could be crystallised from the mixture: mp 217–
221 ЊC (partial decomposition), (from ethyl acetate)]: νmax/cmϪ1
2930, 2854, 1597, 1346, 1307, 1166, 1117; 1H NMR (400 MHz,
C6D6) Z-isomer δ 8.03 (2H, d, J 7.6, Ar-H), 7.75 (1H, t, J 7.6,
Ar-H), 7.65 (2H, t, J 7.6, Ar-H), 7.22 (2H, d, J 8.2, Ar-H),
7.08 (2H, d, J 8.2, Ar-H), 6.11 (1H, br s, 12-H), 5.57–5.45 (2H,
m, 7-H, 8-H), 4.75 (1H, d, J 9.0, 2-H), 4.05–4.00 (1H, m, 10-H),
2.37 (3H, s, CH3) 2.53–1.37 (12H, m, CH2); characteristic peaks
of E-isomer δ 6.06 (1H, br s, 12-H) 3.96–3.94 (1H, m, 10-H);
13C NMR (100 MHz, C6D6) both isomers δ 143.7, 143.6, 139.2,
138.8, 138.2, 134.2, 134.0 (Ar-C, 1), 133.6, 133.2, 132.3 (Ar-C,
7 or 8), 129.5, 129.4, 129.0, 128.8, 127.5, 127.4 (Ar-C), 126.8,
124.1, 120.0, 118.9 (7 or 8, 12), 63.5, 63.3, 62.2, 61.1 (2, 10),
39.5, 33.3, 32.4, 29.7, 29.2, 28.2, 26.4, 24.8, 23.7, 23.2, 21.5, 21.1
(CH2), 21.5 (CH3); m/z 471 (Mϩ, 12%), 330 (90), 262 (38), 162
(92), 91 (100) (Found Mϩ: 471.1551. Calc. for C25H29NO4S2:
471.1538).
᎐
2
2
3.91–3.85 (1H, m, 2-H), 2.49–2.40 (1H, m, CH CH᎐CH ), 2.40
᎐
2
2
(3H, s, CH ), 2.25–2.18 (1H, m, CH CH᎐CH ), 2.06–1.77,
᎐
3
2
2
1.56–1.27 (12H, m, CH2); characteristic peaks of minor diastere-
omer (2S*, 1ЈR*) δ 5.46 (1H, m, 4-H), 3.97–3.94 (1H, m, 2-H);
13C NMR (100 MHz, C6D6) δ 143.8, 138.9, 138.8, 136.5, 134.7,
133.7, 133.4, 129.6, 129.2, 128.8, 128.0 (Ar-C, 5, 7Ј), 118.2 (8Ј or
CH CH᎐CH ), 117.3 (4), 114.4 (8Ј or CH CH᎐CH ), 62.6, 61.2
᎐
᎐
2
2
2
2
(2, 1Ј), 39.7 (CH CH᎐CH ), 33.5, 32.8, 32.6, 28.6, 28.4, 25.8
᎐
2
2
(CH2), 21.6 (CH3); m/z 513 (Mϩ, 10%), 472 (32), 330 (43), 234
(37), 162 (60), 91 (100) (Found Mϩ: 513.2017. Calc. for
C28H35NO4S2: 513.2008).
General procedure B: preparation of macrocycles 12a–d via
ring-closing metathesis
A solution of triene 11a (71 mg, 0.15 mmol) in dichlorometh-
ane (150 ml, 1 mM concentration) was thoroughly degassed
with a vigorous stream of nitrogen and Grubbs’ catalyst
(Cy P) Cl Ru᎐CHPh (25 mg, 0.20 equiv.) was added. The solu-
᎐
3
2
2
tion was heated at 40 ЊC for 16 h. After cooling to room tem-
perature a stream of air was bubbled through the solution and
the solvent was removed in vacuo. Column chromatography
(1:6 ethyl acetate–petroleum ether) afforded macrocycle 12a.
(2S*,11S*,E)- and (2S*,11S*,Z)-2-Phenylsulfonyl-14-(4-
tolylsulfonyl)-14-azabicyclo[9.2.1]tetradeca-1(13),8-diene (12d).
According to general procedure B, a metathesis reaction on
triene 11d (86 mg, 168 µmol) afforded bicycle 12d (62 mg, 77%)
(2S*,8S*,Z)-2-Phenylsulfonyl-11-(4-tolylsulfonyl)-11-aza-
bicyclo[6.2.1]undeca-1(10),5-diene (12a). According to General
procedure B, a metathesis reaction on triene 11a (71 mg, 0.15
mmol) afforded bicycle 12a (32 mg, 48%) as a white solid and as
as a colourless oil and as a 40:60 mixture of E/Z-isomers: νmax
/
cmϪ1 2924, 2855, 1598, 1343, 1307, 1152; 1H NMR (400 MHz,
C6D6) Z-isomer δ 8.12 (2H, d, J 8.2, Ar-H), 8.03 (2H, d, J 7.3,
Ar-H), 7.67 (1H, t, J 7.3, Ar-H), 7.58 (2H, t, J 7.3, Ar-H), 7.30
(2H, d, J 8.2, Ar-H), 5.91 (1H, s, 13-H), 5.63–5.58 (1H, m, 8-H
or 9-H), 5.46–5.40 (1H, m, 8-H or 9-H), 4.99–4.95 (1H, m,
2-H), 4.14–4.09 (1H, m, 11-H), 2.69–2.66 (1H, m, 10-H), 2.42
(3H, s, CH3), 2.26–1.52 (13H, m, CH2); characteristic peaks of
E-isomer δ 5.19–5.24 (1H, m, 2-H), 4.01–3.96 (1H, m, 11-H);
13C NMR (100 MHz, C6D6) both isomers δ 143.7, 138.7, 135.3,
135.1, 133.5, 129.4, 129.0, 128.6, 128.6 (Ar-C, 1), 135.6, 122.3
(8, 9), 114.9 (13), 62.1, 61.4 (2, 11), 34.4, 33.1, 32.9, 32.4, 27.4,
24.6, 23.8 (CH2), 21.5 (CH3); m/z (FAB) 486 (MHϩ, 15%), 344
(15), 154 (35), 136 (37), 55 (100) (Found MHϩ: 486.1782. Calc.
for C26H32NO4S2 486.1773).
a single Z-isomer: mp 183–184 ЊC (from ethyl acetate); νmax
/
1
cmϪ1 2924, 2853, 1597, 1347, 1307, 1165, 1149; H NMR (400
MHz, C6D6) δ 8.01 (2H, d, J 7.5, Ar-H), 7.71 (1H, t, J 7.5,
Ar-H), 7.62 (2H, t, J 7.5, Ar-H), 7.49 (2H, d, J 8.2, Ar-H), 7.19
(2H, d, J 8.2, Ar-H), 5.92 (1H, m, 10-H), 5.57–5.55 (1H, m, 5-H
or 6-H), 5.48–5.44 (1H, m, 5-H or 6-H), 5.15–5.11 (1H, m,
2-H), 3.99–3.97 (1H, m, 8-H), 2.90–2.87 (1H, m, 4-H), 2.66–
2.61 (1H, m, 7-H), 2.40 (3H, s, CH3), 2.14–1.91 (4H, m, CH2),
1.79–1.74 (1H, m, 9-H), 1.67–1.60 (1H, m, 9-H); 13C NMR (100
MHz, C6D6) δ 143.7, 138.5, 134.5, 133.7, 133.7, 129.4, 129.1,
129.1, 127.8 (Ar-C, 1), 137.1 (5 or 6), 123.7, 122.9 (5 or 6, 10),
62.0, 61.0 (2, 8), 32.7, 30.8, 28.9, 23.6 (3, 4, 7, 9), 21.5 (CH3);
m/z 443 (Mϩ, 67%), 378 (15), 303 (100), 248 (60), 234 (53),
210 (30), 146 (100), 91 (100) (Found Mϩ: 443.1217. Calc. for
C23H25NO4S2: 443.1225).
General procedure C: preparation of reduced macrocycles 2a–d
via hydrogenation reactions
To a solution of bicycle 12b (17 mg, 37 µmol) in ethyl acetate
(3 ml) was added platinum() oxide (6 mg, 21 µmol, 0.57 equiv.)
and the mixture was stirred under an atmosphere of hydrogen
for 16 h. Filtration through Celite and silica and removal of
solvent in vacuo afforded hydrogenated bicycle 2b.
(2S*,9S*,E)-
and
(2S*,9S*,Z)-2-Phenylsulfonyl-12-(4-
tolylsulfonyl)-12-azabicyclo[7.2.1]dodeca-1(11),6-diene (12b).
According to general procedure B, a metathesis reaction on
triene 11b (150 mg, 309 µmol) afforded bicycle 12b (114 mg,
81%) as a colourless oil and as a 21:79 mixture of E/Z-isomers:
νmax/cmϪ1 2927, 2854, 1597, 1343, 1308, 1163, 1152; H NMR
1
(400 MHz, C6D6) Z-isomer δ 8.02 (2H, d, J 7.6, Ar-H), 7.93
(2H, d, J 8.2, Ar-H), 7.67 (1H, t, J 7.6, Ar-H), 7.59 (2H, t, J 7.6,
Ar-H), 7.27 (2H, d, J 8.2, Ar-H), 5.85 (1H, br s, 11-H), 5.41
(2H, m, 6-H, 7-H), 4.79 (1H, d, J 10.3, 2-H), 4.14–4.09 (1H, m,
9-H), 3.09–3.04 (1H, m, 5-H), 2.80–2.75 (1H, m, 8-H), 2.41
(2S*,8S*)-2-Phenylsulfonyl-11-(4-tolylsulfonyl)-11-aza-
bicyclo[6.2.1]undeca-1(10)-ene (2a). According to general pro-
cedure C, hydrogenation of bicycle 12a (19 mg, 43 µmol)
afforded hydrogenated bicycle 2a (19 mg, 100%) as a white
solid: mp 186 ЊC (from ethyl acetate); νmax/cmϪ1 2935 (br), 1597,
350
J. Chem. Soc., Perkin Trans. 1, 2000, 345–351